Furthermore, the assessment of AKR levels potentially constitutes a means to discriminate between the relative functionality of KEAP1 and NRF2 mutations and, ultimately, whether they are likely to influence tumour phenotype. The gene discussed is NFE2L2; the disease is neoplasm.